Credit: Shutterstock photoMediWound, which is developing treatments for severe burns and other hard-to-heal wounds, raised $70 million by offering 5.0 million shares at $14, the low end of the $14 to $16 range. MediWound plans to list on the NASDAQ under the symbol MDWD. Credit Suisse, Jefferies and BMO Capital Markets acted as joint bookrunners on the deal.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
